The Effect of Dicumarol on the Erythrocyte Sedimentation Rate in Normal Men

Abstract
OUR interest in the possible effect of dicumarol [3, 3′-methylenebis (4–hydroxycoumarin)] on the erythrocyte sedimentation rate in human beings was aroused when we began to use the drug in an increasing number of cases of acute myocardial infarction. Experience suggested that the sedimentation rates in the patients receiving dicumarol remained elevated over a longer period than would otherwise have occurred, especially when judged in terms of general clinical progress. As is well known, the sedimentation rate is one of the most valuable of the available tests in following the course of these patients. When the question of the influence of . . .

This publication has 2 references indexed in Scilit: